Drug intelligence / Profile preview

vitamin d + omega-3-acid ethyl esters

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Vitamin d + omega-3-acid ethyl esters** is a combination of vitamin D, typically used as cholecalciferol, and prescription omega-3-acid ethyl esters containing primarily the ethyl esters of eicosapentaenoic acid and docosahexaenoic acid. As a combination, it does not represent a single approved INN product but rather concurrent supplementation or co-packaged use of two active ingredients with distinct mechanisms: vitamin D is converted to active vitamin D metabolites that signal through the vitamin D receptor to regulate calcium-phosphate homeostasis and broad immunometabolic pathways, while omega-3-acid ethyl esters alter hepatic triglyceride metabolism and very-low-density lipoprotein handling, lowering serum triglycerides. This combination has been studied most prominently in preventive settings such as the VITAL trial, in which vitamin D3 and Omacor fish oil were tested factorially for primary prevention of cancer and cardiovascular disease, rather than as a uniquely branded fixed-dose pharmaceutical. In practice, the combination sits at the intersection of dietary supplementation and drug therapy, with omega-3-acid ethyl esters being a prescription pharmaceutical for severe hypertriglyceridemia and vitamin D commonly used as a nutritional supplement or deficiency treatment.

Other names
vitamin d + omega-3-acid ethyl estersvitamin D3 + omega-3-acid ethyl esterscholecalciferol + omega-3-acid ethyl esters
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on vitamin d + omega-3-acid ethyl esters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin d + omega-3-acid ethyl esters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call